Elena Lucarini
Overview
Explore the profile of Elena Lucarini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucarini E, DAntongiovanni V, Antonioli L, Ghelardini C, Di Cesare Mannelli L, Ferraroni M, et al.
ACS Med Chem Lett
. 2025 Feb;
16(2):347.
PMID: 39967648
[This corrects the article DOI: 10.1021/acsmedchemlett.4c00284.].
2.
Lucarini E, Aguilera-Lizarraga J, Tejada M
Front Pharmacol
. 2025 Feb;
16:1546059.
PMID: 39944623
No abstract available.
3.
Micheli L, Nobili S, Lucarini E, Toti A, Margiotta F, Ciampi C, et al.
Pharmacol Res
. 2024 Oct;
209:107472.
PMID: 39448045
Growing evidence suggests that opioid analgesics modulate angiogenesis during pathophysiological processes. Vascular endothelial growth factor-A (VEGF-A) was recently proposed to be involved in pain development. To date, no anti-angiogenic drug...
4.
Lucarini E, Benvenuti L, Di Salvo C, DAntongiovanni V, Pellegrini C, Valdiserra G, et al.
Front Pharmacol
. 2024 Oct;
15:1466824.
PMID: 39372212
Introduction: Visceral pain represents the most common digestive issue, frequently resulting from long-term inflammation, such as inflammatory bowel diseases. The lack of effective drugs prompted search of new therapeutic approaches....
5.
Lucarini E, DAntogiovanni V, Antonioli L, Ghelardini C, Di Cesare Mannelli L, Ferraroni M, et al.
ACS Med Chem Lett
. 2024 Sep;
15(9):1559-1565.
PMID: 39291024
Carbonic anhydrase (CA) inhibitors represent intriguing tools for treating pain. This study aims at studying the pharmacological profile of chalcogen bioisosteres of aspirin, as inhibitors of CA isoforms (hCA I,...
6.
DAntongiovanni V, Pellegrini C, Benvenuti L, Fornai M, Di Salvo C, Natale G, et al.
Inflammation
. 2024 Sep;
PMID: 39276301
No abstract available.
7.
Libero M, Lucarini E, Recinella L, Ciampi C, Veschi S, Piro A, et al.
Phytother Res
. 2024 Jun;
38(8):4177-4188.
PMID: 38923108
Inflammatory bowel disease (IBD) is a morbid condition characterized by relapsing-remitting inflammation of the colon, accompanied by persistent gut dysmotility and abdominal pain. Different reports demonstrated biological activities of aged...
8.
Costa A, Lucarini E
Nutr Neurosci
. 2024 Jun;
28(2):221-244.
PMID: 38889540
Chronic stress and chronic pain are closely linked by the capacity to exacerbate each other, sharing common roots in the brain and in the gut. The strict intersection between these...
9.
Di Salvo C, DAntongiovanni V, Benvenuti L, Fornai M, Valdiserra G, Natale G, et al.
J Drug Target
. 2024 Jun;
32(8):953-963.
PMID: 38864378
Nowadays, the pharmacological management of visceral hypersensitivity associated with colitis is ineffective. In this context, targeting purinergic P2X4 receptor (P2X4R), which can modulate visceral pain transmission, could represent a promising...
10.
Micheli L, Parisio C, Lucarini E, Vona A, Toti A, Pacini A, et al.
J Exp Clin Cancer Res
. 2024 Apr;
43(1):120.
PMID: 38650002
No abstract available.